Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists
Background Down-scheduling one or more triptans to Schedule 3 (Pharmacist Only Medicine) from Schedule 4 (Prescription Only Medicine) has been debated in Australia for a decade. This study aimed to evaluate the perspectives and readiness of Western Australian (WA) community pharmacists to manage mig...
Main Authors: | Shaid Booth, Richard Parsons, Bruce Sunderland, Tin Fei Sim |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-12-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/8134.pdf |
Similar Items
-
Triptans in treatment of migraine
by: V. A. Golovacheva, et al.
Published: (2015-12-01) -
Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
by: Elisa Rubino, et al.
Published: (2022-12-01) -
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
by: Simona Sacco, et al.
Published: (2022-10-01) -
Cardiovascular safety of triptans in the acute treatment of migraine
by: G. R. Tabeyeva
Published: (2014-12-01) -
Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug
by: Krymchantowski Abouch V., et al.
Published: (2001-01-01)